Lexeo Therapeutics . Common Stock Stock Forecast

Sell candidate since Jun 23, 2026

The Lexeo Therapeutics, Inc. Common Stock stock price fell by -2.38% on the last day (Tuesday, 23rd Jun 2026) from $5.04 to $4.92. During the last trading day the stock fluctuated 7.14% from a day low at $4.90 to a day high of $5.25. The price has risen in 7 of the last 10 days and is up by 16.86% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -435 thousand shares and in total, 753 thousand shares were bought and sold for approximately $3.71 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.50% during the next 3 months and, with a 90% probability hold a price between $2.94 and $4.22 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LXEO Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lexeo Therapeutics, Inc. Common Stock stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.04. On a fall, the stock will find some support from the short-term average at $4.81. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -2.38%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Lexeo Therapeutics, Inc. Common Stock stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.65 and $4.48. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Lexeo Therapeutics, Inc. Common Stock finds support just below today's level at $4.65. If this is broken, then the next support from accumulated volume will be at $4.48 and $4.37.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.350 between high and low, or 7.14%. For the last week, the stock has had daily average volatility of 7.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LXEO) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Lexeo Therapeutics, Inc. Common Stock to open at $5.02, and during the day (based on 14 day Average True Range), to move between $4.73 and $5.11, which gives a possible trading interval of +/-$0.377 (+/-7.96%) up or down from last closing price. If Lexeo Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 7.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.98 (1.22%) than the support at $4.65 (5.49%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Lexeo Therapeutics, Inc. Common Stock stock A Buy?

Lexeo Therapeutics, Inc. Common Stock holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.076 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $5.02 ( 2.10%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk